HRP20100253T1 - Makrolidi - Google Patents
Makrolidi Download PDFInfo
- Publication number
- HRP20100253T1 HRP20100253T1 HR20100253T HRP20100253T HRP20100253T1 HR P20100253 T1 HRP20100253 T1 HR P20100253T1 HR 20100253 T HR20100253 T HR 20100253T HR P20100253 T HRP20100253 T HR P20100253T HR P20100253 T1 HRP20100253 T1 HR P20100253T1
- Authority
- HR
- Croatia
- Prior art keywords
- alkyl
- diradical
- substituted
- methyl
- oxo
- Prior art date
Links
- 239000003120 macrolide antibiotic agent Substances 0.000 title 1
- 229940041033 macrolides Drugs 0.000 title 1
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract 38
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims abstract 32
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims abstract 23
- 150000001875 compounds Chemical class 0.000 claims abstract 21
- 125000000217 alkyl group Chemical group 0.000 claims abstract 15
- 125000001424 substituent group Chemical group 0.000 claims abstract 14
- 125000004043 oxo group Chemical group O=* 0.000 claims abstract 12
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims abstract 11
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims abstract 11
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 claims abstract 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract 7
- 229910052799 carbon Inorganic materials 0.000 claims abstract 7
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 claims abstract 6
- 125000006710 (C2-C12) alkenyl group Chemical group 0.000 claims abstract 6
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims abstract 4
- 125000006711 (C2-C12) alkynyl group Chemical group 0.000 claims abstract 2
- 125000003627 8 membered carbocyclic group Chemical group 0.000 claims abstract 2
- 101100495917 Arabidopsis thaliana ATRX gene Proteins 0.000 claims abstract 2
- 101001043818 Mus musculus Interleukin-31 receptor subunit alpha Proteins 0.000 claims abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract 2
- -1 hydrocarbon radical Chemical class 0.000 claims 64
- 229960003276 erythromycin Drugs 0.000 claims 23
- 229910020008 S(O) Inorganic materials 0.000 claims 12
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 11
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 8
- JNCMHMUGTWEVOZ-UHFFFAOYSA-N F[CH]F Chemical compound F[CH]F JNCMHMUGTWEVOZ-UHFFFAOYSA-N 0.000 claims 7
- 108010081348 HRT1 protein Hairy Proteins 0.000 claims 7
- 102100021881 Hairy/enhancer-of-split related with YRPW motif protein 1 Human genes 0.000 claims 7
- 125000001589 carboacyl group Chemical group 0.000 claims 7
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 claims 7
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 7
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 5
- 229930006677 Erythromycin A Natural products 0.000 claims 4
- 125000004122 cyclic group Chemical group 0.000 claims 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 4
- 125000004429 atom Chemical group 0.000 claims 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 3
- 125000000027 (C1-C10) alkoxy group Chemical group 0.000 claims 2
- 125000005862 (C1-C6)alkanoyl group Chemical group 0.000 claims 2
- 125000006592 (C2-C3) alkenyl group Chemical group 0.000 claims 2
- 125000006593 (C2-C3) alkynyl group Chemical group 0.000 claims 2
- 239000004215 Carbon black (E152) Substances 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 125000005842 heteroatom Chemical group 0.000 claims 2
- 229930195733 hydrocarbon Natural products 0.000 claims 2
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 claims 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims 2
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 claims 2
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 claims 2
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims 2
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 claims 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 1
- 125000004209 (C1-C8) alkyl group Chemical class 0.000 claims 1
- 125000005955 1H-indazolyl group Chemical group 0.000 claims 1
- 125000002471 4H-quinolizinyl group Chemical group C=1(C=CCN2C=CC=CC12)* 0.000 claims 1
- 208000035143 Bacterial infection Diseases 0.000 claims 1
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 claims 1
- 241000193996 Streptococcus pyogenes Species 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 208000022362 bacterial infectious disease Diseases 0.000 claims 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims 1
- 125000005605 benzo group Chemical group 0.000 claims 1
- 125000005873 benzo[d]thiazolyl group Chemical group 0.000 claims 1
- 125000002619 bicyclic group Chemical group 0.000 claims 1
- 125000002837 carbocyclic group Chemical group 0.000 claims 1
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 claims 1
- 229960002626 clarithromycin Drugs 0.000 claims 1
- AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 claims 1
- 125000001041 indolyl group Chemical group 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 125000006413 ring segment Chemical group 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Tires In General (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63809704P | 2004-12-21 | 2004-12-21 | |
| US71753005P | 2005-09-14 | 2005-09-14 | |
| PCT/IB2005/003829 WO2006067589A1 (fr) | 2004-12-21 | 2005-12-12 | Macrolides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20100253T1 true HRP20100253T1 (hr) | 2010-06-30 |
Family
ID=35809765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20100253T HRP20100253T1 (hr) | 2004-12-21 | 2010-05-04 | Makrolidi |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US7462600B2 (fr) |
| EP (2) | EP1836211B1 (fr) |
| JP (1) | JP4111994B1 (fr) |
| KR (1) | KR100897678B1 (fr) |
| CN (1) | CN101120011A (fr) |
| AP (1) | AP2007004026A0 (fr) |
| AR (1) | AR052824A1 (fr) |
| AT (1) | ATE459633T1 (fr) |
| AU (1) | AU2005317735B2 (fr) |
| BR (1) | BRPI0519135A2 (fr) |
| CA (1) | CA2591746A1 (fr) |
| CR (1) | CR9202A (fr) |
| DE (1) | DE602005019786D1 (fr) |
| DK (1) | DK1836211T3 (fr) |
| EA (1) | EA011281B1 (fr) |
| ES (1) | ES2339871T3 (fr) |
| GE (1) | GEP20094834B (fr) |
| GT (1) | GT200500378A (fr) |
| HN (1) | HN2005036113A (fr) |
| HR (1) | HRP20100253T1 (fr) |
| IL (1) | IL183661A0 (fr) |
| MA (1) | MA29108B1 (fr) |
| MX (1) | MX2007007598A (fr) |
| NL (1) | NL1030713C2 (fr) |
| NO (1) | NO20073367L (fr) |
| PE (1) | PE20060948A1 (fr) |
| PL (1) | PL1836211T3 (fr) |
| PT (1) | PT1836211E (fr) |
| SI (1) | SI1836211T1 (fr) |
| TN (1) | TNSN07233A1 (fr) |
| TW (1) | TW200626608A (fr) |
| UA (1) | UA85937C2 (fr) |
| UY (1) | UY29285A1 (fr) |
| WO (1) | WO2006067589A1 (fr) |
| ZA (1) | ZA200705108B (fr) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9133212B1 (en) | 2005-06-15 | 2015-09-15 | Vanderbilt University | Inhibitors of hemeprotein-catalyzed lipid peroxidation |
| US8367669B2 (en) * | 2005-06-15 | 2013-02-05 | Vanderbilt University | Inhibitors of hemeprotein-catalyzed lipid peroxidation |
| DK1934238T3 (en) | 2005-08-24 | 2017-09-18 | Melinta Therapeutics Inc | TRIAZOL COMPOUNDS AND METHODS FOR THE PREPARATION AND USE OF THESE |
| CN101631795A (zh) * | 2007-03-13 | 2010-01-20 | 辉瑞产品公司 | 基于红霉素的大环内酯 |
| EP2136806A4 (fr) * | 2007-03-21 | 2011-11-23 | Creative Antibiotics Sweden Ab | Procédé et moyens pour prévenir et inhiber une sécrétion de type iii dans des infections provoquées par une bactérie à gram-négatif |
| JP5698979B2 (ja) | 2007-10-25 | 2015-04-08 | センプラ ファーマシューティカルズ，インコーポレイテッド | マクロライド系抗菌剤の調製プロセス |
| WO2009053259A1 (fr) * | 2007-10-25 | 2009-04-30 | Sandoz Ag | Procédé de fabrication de télithromycine |
| CN101903382B (zh) | 2007-12-21 | 2012-11-28 | 弗·哈夫曼-拉罗切有限公司 | 杂环抗病毒化合物 |
| JP5662445B2 (ja) * | 2009-08-13 | 2015-01-28 | バジリア ファルマスーチカ アーゲーＢａｓｉｌｅａ Ｐｈａｒｍａｃｅｕｔｉｃａ ＡＧ | 新規マクロライド及びその使用 |
| DK2550286T3 (en) * | 2010-03-22 | 2016-02-29 | Cempra Pharmaceuticals Inc | CRYSTALLINE FORMS OF A MACROLID AND APPLICATIONS THEREOF |
| EP2696873B1 (fr) | 2011-04-12 | 2022-08-03 | The United States of America, as represented by The Secretary, Department of Health and Human Services | Inhibiteurs du canal anionique de surface de plasmodium pour le traitement ou la prévention de la malaria |
| CN102558047B (zh) * | 2011-12-14 | 2013-10-30 | 天津药物研究院药业有限责任公司 | 3-甲基喹啉的制备方法 |
| US10188674B2 (en) | 2012-03-27 | 2019-01-29 | Cempra Pharmaceuticals, Inc. | Parenteral formulations for administering macrolide antibiotics |
| RU2015103119A (ru) | 2012-07-13 | 2016-08-27 | Ф. Хоффманн-Ля Рош Аг | Антипролиферативные бензо[в]азепин-2-оны |
| KR101663864B1 (ko) * | 2013-04-19 | 2016-10-07 | 영남대학교 산학협력단 | 아미도피리딘올 유도체 또는 이의 약제학적 허용가능한 염을 유효성분으로 함유하는 염증성 장질환의 예방 또는 치료용 약학조성물 |
| TW201534586A (zh) | 2013-06-11 | 2015-09-16 | Orion Corp | 新穎ｃｙｐ１７抑制劑／抗雄激素劑 |
| CN103739643A (zh) * | 2013-12-30 | 2014-04-23 | 华东理工大学 | 利用分子印迹技术对红霉素进行回收分离纯化的方法 |
| CN104230891B (zh) * | 2014-08-27 | 2016-03-30 | 于宗光 | 一种托匹司他的制备方法 |
| EP3522896A4 (fr) | 2016-10-04 | 2020-06-17 | Biopharmati SA | Cétolides à activité antibactrienne |
| JP2022534709A (ja) * | 2019-06-04 | 2022-08-03 | ヘイガー バイオサイエンシズ，エルエルシー | オレキシンアンタゴニストとしてのピラゾール及びイミダゾール誘導体、組成物、並びに方法 |
| CN111793022A (zh) * | 2020-04-27 | 2020-10-20 | 滁州拜奥生物科技有限公司 | 一种3-甲基喹啉的制备方法 |
| WO2024050061A2 (fr) * | 2022-09-01 | 2024-03-07 | Hager Biosciences, Llc | Dérivés de pyrazole et d'imidazole utilisés en tant que modulateurs des récepteurs double d'orexine et d'opioïdes kappa, composition, procédés de traitement de troubles neurologiques et psychiatriques |
Family Cites Families (74)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2653899A (en) | 1952-04-14 | 1953-09-29 | Lilly Co Eli | Erythromycin, its salts, and method of preparation |
| US2823203A (en) | 1954-06-24 | 1958-02-11 | Abbott Lab | Method of producing substantially pure erythromycin a |
| US4331803A (en) | 1980-06-04 | 1982-05-25 | Taisho Pharmaceutical Co., Ltd. | Novel erythromycin compounds |
| SI8110592A8 (en) | 1981-03-06 | 1996-06-30 | Pliva Pharm & Chem Works | Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof |
| US4474768A (en) | 1982-07-19 | 1984-10-02 | Pfizer Inc. | N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor |
| US4742049A (en) * | 1986-06-04 | 1988-05-03 | Abbott Laboratories | Semisynthetic erythromycin antibiotics |
| US5075289A (en) | 1988-06-07 | 1991-12-24 | Abbott Laboratories | 9-r-azacyclic erythromycin antibiotics |
| IE70593B1 (en) | 1989-09-29 | 1996-12-11 | Eisai Co Ltd | Biphenylmethane derivative the use of it and pharmacological compositions containing same |
| US5523399A (en) | 1991-12-27 | 1996-06-04 | Taisho Pharmaceutical Co., Ltd. | 5-O-desosaminylerythronolide derivatives |
| FR2697524B1 (fr) * | 1992-11-05 | 1994-12-23 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
| US5527780A (en) | 1992-11-05 | 1996-06-18 | Roussel Uclaf | Erythromycin derivatives |
| FR2719587B1 (fr) | 1994-05-03 | 1996-07-12 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
| US5629322A (en) | 1994-11-15 | 1997-05-13 | Merck & Co., Inc. | Cyclic amidine analogs as inhibitors of nitric oxide synthase |
| FR2727969B1 (fr) * | 1994-12-09 | 1997-01-17 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
| US5747466A (en) * | 1995-11-08 | 1998-05-05 | Abbott Laboratories | 3-deoxy-3-descladinose derivatives of erythromycins A and B |
| FR2742757B1 (fr) | 1995-12-22 | 1998-01-30 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
| EP0918783A1 (fr) * | 1996-05-07 | 1999-06-02 | Abbott Laboratories | Erythromycines 6-o substituees et leur procede de preparation |
| US5750510A (en) * | 1997-04-04 | 1998-05-12 | Abbott Laboratories | 3-descladinose-2,3-anhydroerythromycin derivatives |
| FR2748746B1 (fr) * | 1996-05-14 | 1998-08-14 | Hoechst Marion Roussel Inc | Nouveau procede d'isomerisation du radical methyle en 10 de derives de l'erythromycine |
| US6271255B1 (en) | 1996-07-05 | 2001-08-07 | Biotica Technology Limited | Erythromycins and process for their preparation |
| FR2751656B1 (fr) * | 1996-07-24 | 1998-10-16 | Hoechst Marion Roussel Inc | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
| ATE296308T1 (de) | 1996-09-04 | 2005-06-15 | Abbott Lab | 6-o-substituierte ketoliden mit antibakteriellen wirkung |
| US5804565A (en) | 1996-09-24 | 1998-09-08 | Taisho Pharmaceutical Co., Ltd. | Erythromycin A derivatives |
| KR20000069138A (ko) | 1996-11-27 | 2000-11-25 | 우에하라 아끼라 | 에리트로마이신 ａ 유도체 |
| AU6421398A (en) | 1997-03-24 | 1998-10-20 | Taisho Pharmaceutical Co., Ltd. | Erythromycin a derivatives |
| AU6932098A (en) | 1997-05-09 | 1998-12-08 | Pfizer Products Inc. | Erythromycin derivatives |
| US20020025937A1 (en) | 2000-03-20 | 2002-02-28 | Yong-Jin Wu | 9-oxime erythromycin derivatives |
| EP0895999A1 (fr) * | 1997-08-06 | 1999-02-10 | Pfizer Products Inc. | Macrolides antibiotiques substitués C"-4 |
| ZA987689B (en) | 1997-09-02 | 1999-02-24 | Abbott Lab | 3-descladinose 6-O substituted erythromycin derivatives |
| US6034069A (en) * | 1997-09-30 | 2000-03-07 | Abbott Laboratories | 3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity |
| ZA989835B (en) | 1997-10-29 | 1999-05-05 | Taisho Pharmaceutical Co Ltd | Erythromycin a derivatives |
| HN1998000159A (es) * | 1997-10-29 | 1999-02-09 | Monsanto Co | Derivados de 9- amino - 3 ceto eritromicina |
| PA8461401A1 (es) | 1997-10-29 | 2000-05-24 | Pfizer Prod Inc | Derivados de eritromicina triciclicos |
| AP1060A (en) * | 1998-01-02 | 2002-04-23 | Pfizer Prod Inc | Novel erythromycin derivatives. |
| AP9801420A0 (en) | 1998-01-02 | 1998-12-31 | Pfizer Prod Inc | Novel macrolides. |
| PT941998E (pt) | 1998-03-03 | 2004-12-31 | Pfizer Prod Inc | Antibioticos macrolidos do tipo 3,6-cetal |
| US5955440A (en) * | 1998-03-27 | 1999-09-21 | Abbott Laboratories | Macrolide LHRH antagonists |
| WO1999062920A1 (fr) | 1998-06-03 | 1999-12-09 | Pfizer Products Inc. | Derives 3-keto tricycliques de 6-o-methylerythromycine |
| JP4573925B2 (ja) * | 1998-07-09 | 2010-11-04 | アベンティス・ファーマ・ソシエテ・アノニム | 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用 |
| US6387885B1 (en) * | 1998-08-26 | 2002-05-14 | Abbott Laboratories | 3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists |
| US6020521A (en) | 1998-08-26 | 2000-02-01 | Abbott Laboratories | Macrolide LHRH antagonists |
| OA11670A (en) | 1998-11-03 | 2005-01-12 | Pfizer Prod Inc | Novel macrolide antibiotics. |
| US6262030B1 (en) | 1998-11-03 | 2001-07-17 | Pfizer Inc. | Erythromycin derivatives |
| EP1137654A1 (fr) * | 1998-12-10 | 2001-10-04 | Pfizer Products Inc. | Antibiotiques a base de cetolides de carbamate et de carbazate |
| DK1147121T3 (da) | 1999-01-27 | 2004-04-13 | Pfizer Prod Inc | Ketolidantibiotika |
| US6054435A (en) * | 1999-03-19 | 2000-04-25 | Abbott Laboratories | 6-O-substituted macrolides having antibacterial activity |
| US6939861B2 (en) | 1999-04-16 | 2005-09-06 | Kosan Biosciences, Inc. | Amido macrolides |
| US6458771B1 (en) * | 1999-04-16 | 2002-10-01 | Ortho-Mcneil Pharmaceutical, Inc. | Ketolide antibacterials |
| WO2000063224A2 (fr) * | 1999-04-16 | 2000-10-26 | Kosan Biosciences, Inc. | ipcNTS ANTI-INFECTIEUX MACROLIDES |
| US20020077302A1 (en) | 1999-04-23 | 2002-06-20 | Yong-Jin Wu | Tricyclic erythromycin derivatives |
| US20020061857A1 (en) | 1999-04-23 | 2002-05-23 | Yong-Jin Wu | 9-amino-3-oxo erythromycin derivatives |
| US6355620B1 (en) * | 1999-05-14 | 2002-03-12 | Abbott Laboratories | C-2 modified erythromycin derivatives |
| SK15162001A3 (sk) | 1999-05-24 | 2003-02-04 | Pfizer Products Inc. | Deriváty 13-metylerytromycínu |
| JP2001072669A (ja) | 1999-09-07 | 2001-03-21 | Showa Kako Kk | ７−クロロ−２，４（１ｈ，３ｈ）−キナゾリンジオンの製造方法 |
| US6569836B2 (en) * | 1999-12-02 | 2003-05-27 | Abbott Laboratories | 6-O-alkyl-2-nor-2-substituted ketolide derivatives |
| EP1114826A3 (fr) | 1999-12-29 | 2001-10-31 | Pfizer Products Inc. | Macrolides antibactériennes et prokinétiques |
| EP1122261A3 (fr) | 2000-01-31 | 2001-09-26 | Pfizer Products Inc. | Macrolides antibactériennes à 13 ou 14 chainons |
| JP2001261694A (ja) | 2000-03-06 | 2001-09-26 | Pfizer Prod Inc | ケトライド抗生物質 |
| EP1146051A3 (fr) | 2000-04-10 | 2001-10-31 | Pfizer Products Inc. | Dérivées de l' érythromycine A |
| US20020061856A1 (en) | 2000-04-24 | 2002-05-23 | Yong-Jin Wu | Novel tricyclic erythromycin derivatives |
| DE60104240T2 (de) | 2000-06-30 | 2005-08-04 | Pfizer Products Inc., Groton | Makrolid-Antibiotika |
| US20020115621A1 (en) | 2000-08-07 | 2002-08-22 | Wei-Gu Su | Macrolide antibiotics |
| CN1492874A (zh) | 2000-12-21 | 2004-04-28 | 大环内酯 | |
| US20020132782A1 (en) * | 2001-01-18 | 2002-09-19 | Zhenkun Ma | 9-amino erythromycin derivatives with antibacterial activity |
| CA2451391A1 (fr) * | 2001-07-03 | 2003-01-16 | Chiron Corporation | Macrolides et cetolides d'erythromycine modifiee c12 a activite antibacterienne |
| US7064110B2 (en) | 2002-05-13 | 2006-06-20 | Enanta Pharmaceuticals, Inc. | 6-11 bicycle ketolide derivatives |
| WO2005070918A1 (fr) | 2002-05-13 | 2005-08-04 | Enanta Pharmaceuticals, Inc. | Procede de preparation de derives bicycliques 6-11 d'erythromycine |
| WO2004094407A1 (fr) | 2003-04-21 | 2004-11-04 | Daiichi Pharmaceutical Co. Ltd. | Derive heterocyclique a cinq chainons |
| WO2006080954A1 (fr) | 2004-07-28 | 2006-08-03 | Ranbaxy Laboratories Limited | Derives de cetolides agents antibacteriens |
| EP1807439A2 (fr) | 2004-10-25 | 2007-07-18 | Ranbaxy Laboratories Limited | Derives de cetolides utiles comme agents antibacteriens |
| GB0424951D0 (en) | 2004-11-11 | 2004-12-15 | Glaxo Group Ltd | Novel compounds |
| JP2008522978A (ja) | 2004-12-07 | 2008-07-03 | エナンタ ファーマシューティカルズ インコーポレイテッド | ３，６−ビシクロライド |
| US7312201B2 (en) | 2004-12-13 | 2007-12-25 | Enanta Pharmaceuticals, Inc. | Tetracyclic bicyclolides |
| WO2006065721A2 (fr) | 2004-12-13 | 2006-06-22 | Enanta Pharmaceuticals, Inc. | Bicyclolides de 11, 12-lactone |
-
2005
- 2005-12-12 BR BRPI0519135-1A patent/BRPI0519135A2/pt not_active IP Right Cessation
- 2005-12-12 EP EP05813939A patent/EP1836211B1/fr active Active
- 2005-12-12 AP AP2007004026A patent/AP2007004026A0/xx unknown
- 2005-12-12 KR KR1020077014160A patent/KR100897678B1/ko not_active IP Right Cessation
- 2005-12-12 JP JP2007547694A patent/JP4111994B1/ja not_active Expired - Fee Related
- 2005-12-12 AT AT05813939T patent/ATE459633T1/de not_active IP Right Cessation
- 2005-12-12 WO PCT/IB2005/003829 patent/WO2006067589A1/fr active Application Filing
- 2005-12-12 MX MX2007007598A patent/MX2007007598A/es active IP Right Grant
- 2005-12-12 CA CA002591746A patent/CA2591746A1/fr not_active Abandoned
- 2005-12-12 CN CNA2005800482465A patent/CN101120011A/zh active Pending
- 2005-12-12 DE DE602005019786T patent/DE602005019786D1/de active Active
- 2005-12-12 EP EP10154783A patent/EP2233493A1/fr not_active Withdrawn
- 2005-12-12 GE GEAP200510142A patent/GEP20094834B/en unknown
- 2005-12-12 PT PT05813939T patent/PT1836211E/pt unknown
- 2005-12-12 EA EA200701113A patent/EA011281B1/ru not_active IP Right Cessation
- 2005-12-12 AU AU2005317735A patent/AU2005317735B2/en not_active Ceased
- 2005-12-12 ES ES05813939T patent/ES2339871T3/es active Active
- 2005-12-12 DK DK05813939.5T patent/DK1836211T3/da active
- 2005-12-12 UA UAA200706959A patent/UA85937C2/uk unknown
- 2005-12-12 SI SI200530941T patent/SI1836211T1/sl unknown
- 2005-12-12 PL PL05813939T patent/PL1836211T3/pl unknown
- 2005-12-14 PE PE2005001462A patent/PE20060948A1/es not_active Application Discontinuation
- 2005-12-19 HN HN2005036113A patent/HN2005036113A/es unknown
- 2005-12-20 TW TW094145385A patent/TW200626608A/zh unknown
- 2005-12-20 GT GT200500378A patent/GT200500378A/es unknown
- 2005-12-20 AR ARP050105370A patent/AR052824A1/es unknown
- 2005-12-20 NL NL1030713A patent/NL1030713C2/nl not_active IP Right Cessation
- 2005-12-21 US US11/313,523 patent/US7462600B2/en not_active Expired - Fee Related
- 2005-12-21 UY UY29285A patent/UY29285A1/es not_active Application Discontinuation
-
2007
- 2007-06-04 IL IL183661A patent/IL183661A0/en unknown
- 2007-06-15 ZA ZA200705108A patent/ZA200705108B/xx unknown
- 2007-06-20 TN TNP2007000233A patent/TNSN07233A1/fr unknown
- 2007-06-21 MA MA30024A patent/MA29108B1/fr unknown
- 2007-06-21 CR CR9202A patent/CR9202A/es not_active Application Discontinuation
- 2007-06-29 NO NO20073367A patent/NO20073367L/no not_active Application Discontinuation
-
2010
- 2010-05-04 HR HR20100253T patent/HRP20100253T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20100253T1 (hr) | Makrolidi | |
| CN111788193B (zh) | Pd-1/pd-l1类小分子抑制剂及其在药物中的应用 | |
| US8173636B2 (en) | Hydroxylthienoquinolones and related compounds as anti-infective agents | |
| AU2004233557B2 (en) | Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections | |
| AU2006272571B2 (en) | 8-methoxy-9H-isothiazolo[5,4-B]quinoline-3,4-diones and related compounds as anti-infective agents | |
| NZ526450A (en) | Macrolide antibiotics | |
| CA2954189A1 (fr) | 2-amino-pyrido [2,3-d] pyrimidin -7 (8h)-one utilises en tant qu'inhibiteurs de cdk et utilisations de ceux-ci | |
| AR060537A1 (es) | 1,2,4-triazoles trisustituidos | |
| AU2006214234B2 (en) | New isothiazoloquinolones and related compounds as anti-infective agents | |
| ES2217579T3 (es) | Derivados de eritromicina cetolidos, modificados en n-3 y sustituidos en o-6, que tiene una actividad antibacteriana. | |
| CA3202944A1 (fr) | Pyrazolothiazole carboxamides et leurs utilisations en tant qu'inhibiteurs de pdgfr | |
| WO2019195846A1 (fr) | Inhibiteurs d'imidazopipérazinone de protéines d'activation de la transcription | |
| ES2256030T3 (es) | 9a-azalidas con actividad antibacteriana. | |
| KR20200005586A (ko) | 박테리아 감염을 치료하는 화합물 및 방법 | |
| WO2009064953A1 (fr) | Utilisation de dérivés de tylosine ou de macrolides pontés pour le traitement d'affections intestinales inflammatoires non spécifiques | |
| EP1809639B1 (fr) | 8a, 9-dihydro-4a-h-isothiazolo[5,4-b] quinoline-3, 4-diones et composes afferents comme agent antiinfectieux | |
| BG63124B1 (bg) | Нови производни на еритромицин, метод за тяхнотополучаване и използването им като лекарствени средства | |
| JP2014058507A (ja) | １１位アミノ置換マクロライド誘導体 | |
| ES2254389T3 (es) | Agentes anti-infecciosos utiles contra cepas bacterianas resistntes a multiples farmacos. | |
| WO2008036420A2 (fr) | 9-(hétéroaryl)-isothiazolo[5,4-b]quinoléine-3,4-diones et composés apparentés en tant qu'agents anti-infectieux | |
| ES2197472T3 (es) | Derivados de eritromicina de ciclos multiples. | |
| WO2013096785A1 (fr) | Thiénoquinolones substituées en position 2 et composés apparentés comme agents anti-infectieux | |
| JP2014058508A (ja) | ９位オキシム置換マクロライド誘導体 | |
| MXPA01000114A (en) | Novel antibacterial and prokinetic macrolides |